Cargando…

Gene Expression Analysis Reveals Distinct Pathways of Resistance to Bevacizumab in Xenograft Models of Human ER-Positive Breast Cancer

Bevacizumab, the recombinant antibody targeting vascular endothelial growth factor (VEGF), improves progression-free but not overall survival in metastatic breast cancer. To seek further insights in resistance mechanisms to bevacizumab at the molecular level, we developed VEGF and non-VEGF-driven ER...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gökmen-Polar, Yesim, Goswami, Chirayu P., Toroni, Rachel A., Sanders, Kerry L., Mehta, Rutika, Sirimalle, Usha, Tanasa, Bogdan, Shen, Changyu, Li, Lang, Ivan, Mircea, Badve, Sunil, Sledge Jr, George W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142325/ https://www.ncbi.nlm.nih.gov/pubmed/25157274 http://dx.doi.org/10.7150/jca.8466

Ejemplares similares

Upregulation of HSF1 in estrogen receptor positive breast cancer
por: Gökmen-Polar, Yesim, et al.
Publicado: (2016)

Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers
por: Gökmen-Polar, Yesim, et al.
Publicado: (2015)

Is conservative management of ductal carcinoma in situ risky?
por: Zheng, Lan, et al.
Publicado: (2022)

Molecular Analysis of Thymoma
por: Badve, Sunil, et al.
Publicado: (2012)

CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer
por: Craven, Kelly E., et al.
Publicado: (2021)

Thymic Carcinomas and Second Malignancies: A Single-Center Review
por: Badve, Sunil S., et al.
Publicado: (2021)

Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients
por: Duchnowska, Renata, et al.
Publicado: (2015)

Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity
por: Bhat-Nakshatri, Poornima, et al.
Publicado: (2013)

Three-dimensional imaging and quantitative analysis in CLARITY processed breast cancer tissues
por: Chen, Yi, et al.
Publicado: (2019)

A Gene Signature to Determine Metastatic Behavior in Thymomas
por: Gökmen-Polar, Yesim, et al.
Publicado: (2013)

Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients
por: Appaiah, Hitesh N, et al.
Publicado: (2011)

Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer
por: Gökmen-Polar, Yesim, et al.
Publicado: (2018)

ColoType: a forty gene signature for consensus molecular subtyping of colorectal cancer tumors using whole-genome assay or targeted RNA-sequencing
por: Buechler, Steven A., et al.
Publicado: (2020)

Spatially variant immune infiltration scoring in human cancer tissues
por: Allam, Mayar, et al.
Publicado: (2022)

Single cell heterogeneity in ductal carcinoma in situ of breast
por: Gerdes, Michael J, et al.
Publicado: (2017)

Genomic clustering analysis identifies molecular subtypes of thymic epithelial tumors independent of World Health Organization histologic type
por: Padda, Sukhmani K., et al.
Publicado: (2021)

Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor–Positive, Early Breast Cancer
por: Buechler, Steven A, et al.
Publicado: (2019)

Predicting Breast Cancer Events in Ductal Carcinoma In Situ (DCIS) Using Generative Adversarial Network Augmented Deep Learning Model
por: Ghose, Soumya, et al.
Publicado: (2023)

Multi-protein spatial signatures in ductal carcinoma in situ (DCIS) of breast
por: Badve, Sunil S., et al.
Publicado: (2021)

Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast
por: Badve, Sunil S., et al.
Publicado: (2022)

A Patient-Derived Xenograft Model of Glioblastoma
por: Chokshi, Chirayu R., et al.
Publicado: (2020)

Zebrafish xenografts as a fast screening platform for bevacizumab cancer therapy
por: Rebelo de Almeida, Cátia, et al.
Publicado: (2020)

Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells
por: Burnett, Riesa M., et al.
Publicado: (2015)

Anti-tumor effect of bevacizumab on a xenograft model of feline mammary carcinoma
por: MICHISHITA, Masaki, et al.
Publicado: (2015)

Biologic Response of Colorectal Cancer Xenograft Tumors to Sequential Treatment with Panitumumab and Bevacizumab
por: Taniguchi, Hiroya, et al.
Publicado: (2018)

Sustained effect of continuous treatment with bevacizumab following bevacizumab in combination with chemotherapy in a human ovarian clear cell carcinoma xenograft model
por: Ishikura, Nobuyuki, et al.
Publicado: (2019)

Bevacizumab counteracts VEGF-dependent resistance to erlotinib in an EGFR-mutated NSCLC xenograft model
por: Masuda, Chinami, et al.
Publicado: (2017)

Protein kinase Cι is required for Ras transformation and colon carcinogenesis in vivo
por: Murray, Nicole R., et al.
Publicado: (2004)

Effective Inhibition of Xenografts of Hepatocellular Carcinoma (HepG2) by Rapamycin and Bevacizumab in an Intrahepatic Model
por: Ong, Lai-Chun, et al.
Publicado: (2009)

Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenografts
por: Nishri, Yossi, et al.
Publicado: (2022)

Cisplatin plus paclitaxel and maintenance of bevacizumab on tumour progression, dissemination, and survival of ovarian carcinoma xenograft models
por: Oliva, P, et al.
Publicado: (2012)

Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model
por: Iwai, Toshiki, et al.
Publicado: (2016)

PROGmiR: a tool for identifying prognostic miRNA biomarkers in multiple cancers using publicly available data
por: Goswami, Chirayu Pankaj, et al.
Publicado: (2012)

PROGgene: gene expression based survival analysis web application for multiple cancers
por: Goswami, Chirayu Pankaj, et al.
Publicado: (2013)

PROGgeneV2: enhancements on the existing database
por: Goswami, Chirayu Pankaj, et al.
Publicado: (2014)

Detection of Rapalog-Mediated Therapeutic Response in Renal Cancer Xenografts Using (64)Cu-bevacizumab ImmunoPET
por: Chang, Albert J., et al.
Publicado: (2013)

Effect of the PIVO Device on the Procedure of Phlebotomy from Peripheral IV Catheters
por: Adams, Suzanne, et al.
Publicado: (2018)

The diagnosis and management of pre-invasive breast disease: another point of view
por: Badve, Sunil
Publicado: (2004)

Artificial intelligence in breast pathology – dawn of a new era
por: Badve, Sunil S.
Publicado: (2023)

Effects of bevacizumab administration on the hypoxia - induced pulmonary hypertension rat model
por: DEMİR, Canan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a5lq85ap9lmuml1mfc54riblh1